The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

Basic local alignment search tool

Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646

Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles

Wiedenmann, B. J., & Franke, W. W. (1985) · Cell · doi:10.1016/s0092-8674(85)80082-9 · Cited by 1,432

Partial Resolution of the Enzymes Catalyzing Oxidative Phosphorylation

Kagawa, Y., & Racker, E. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61930-1 · Cited by 1,361

Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases

Kennelly, P. J., & Krebs, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98436-x · Cited by 1,331

Crossroads between copper ions and amyloid formation in Parkinson’s disease

Wittung-Stafshede, P. E. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220043 · Cited by 18

Effect of flavonoids on the destabilization of α-synuclein fibrils and their conversion to amorphous aggregate: A molecular dynamics simulation and experimental study

Jahan, I., Ahmad, A., & Deep, S. (2023) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2023.140951 · Cited by 18

Effect of the A30P mutation on the structural dynamics of micelle-bound αSynuclein released in water: a molecular dynamics study

Chatterjee, P., & Sengupta, N. (2012) · European Biophysics Journal · doi:10.1007/s00249-012-0803-y · Cited by 18

α‐Synuclein Oligomers: A Study in Diversity

van Diggelen, F., Tepper, A. W. J. W., Apetri, M. M., & Otzen, D. E. (2016) · Israel Journal of Chemistry · doi:10.1002/ijch.201600116 · Cited by 18

Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer’s Disease

Kong, C., Xie, H., Gao, Z., Shao, M., Li, H., Shi, R., Cai, L., Gao, S., Sun, T., & Li, C. (2019) · Virologica Sinica · doi:10.1007/s12250-019-00124-1 · Cited by 18

CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein

Valente, T., Dentesano, G., Ezquerra, M., Fernández‐Santiago, R., Martinez-Martin, J., Gallastegui, E., Domuro, C., Compta, Y., Martı́, M. J., Bachs, O., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0368-8 · Cited by 18

Salient Features of Monomeric Alpha-Synuclein Revealed by NMR Spectroscopy

Kim, D.-H., Lee, J., Mok, K. H., Lee, J., & Han, K. (2020) · Biomolecules · doi:10.3390/biom10030428 · Cited by 18

Current experimental disease-modifying therapeutics for multiple system atrophy

Lemos, M., Wenning, G. K., & Stefanova, N. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02406-z · Cited by 17

Stressor‐related impairment of synaptic transmission in hippocampal slices from α‐synuclein knockout mice

Martín, E. D., Gonzalez-Garcia, C., Milán, M., Fariñas, I., & Ceña, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03801.x · Cited by 18

Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity

Gupta, V. R., Salim, S., Hmila, I., Vaikath, N. N., Sudhakaran, I. P., Ghanem, S. S., Majbour, N. K., Abdulla, S. A., Emara, M. M., Abdesselem, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65035-8 · Cited by 18

β-Synuclein-Derived Peptides With Neuroprotective Activity: An Alternative Treatment of Neurodegenerative Disorders?

Windisch, M., Hutter‐Paier, B., Schreiner, E., & Wronski, R. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:1:155 · Cited by 18

Impairment in the mesohippocampal dopamine circuit following exposure to the brominated flame retardant, HBCDD

Pham-Lake, C., Aronoff, E. B., Camp, C. R., Vester, A. I., Peters, S. J., & Caudle, W. M. (2017) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2017.02.003 · Cited by 17

Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex

Li, X., Zhang, Y., Fu, Y., Zhang, H., Li, H.-X., Li, Q., Li, H., Tan, R., Jiang, C.-X., Jiang, W., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00605-0 · Cited by 18

α-Synuclein expression in the brain and blood during abstinence from chronic alcohol drinking in mice

Ziółkowska, B., Gieryk, A., Wawrzczak‐Bargieła, A., KROWKA, T., Kamińska, D., Korkosz, A., Bieńkowski, P., & Przewłocki, R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.001 · Cited by 17

Products of Cu( ii )-catalyzed oxidation of α-synuclein fragments containing M 1 -D 2 and H 50 residues in the presence of hydrogen peroxide

Kowalik‐Jankowska, T., Rajewska, A., Jankowska, E., & Grzonka, Z. (2008) · Dalton Transactions · doi:10.1039/b714440g · Cited by 17

Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent Neurons

Pathak, D., Berthet, A., Bendor, J., Yu, K., Sellnow, R. C., Orr, A. L., Nguyen, M. K., Edwards, R. H., Manfredsson, F. P., & Nakamura, K. (2017) · eNeuro · doi:10.1523/eneuro.0216-16.2017 · Cited by 16

Pathology of Parkinson's Disease

Halliday, G. M., & Murphy, K. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00009-x · Cited by 17

Progressive accumulation of ubiquitin and disappearance of α-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas-Braak method

Sakamoto, M., Uchihara, T., Nakamura, A., Mizutani, T., & Mizusawa, H. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1066-9 · Cited by 17

Failure to replicate a protective effect of allele 2 of NACP/α‐synuclein polymorphism in Alzheimer's disease: An association study

Hellman, N. E., Grant, E., & Goate, A. (1998) · Annals of Neurology · doi:10.1002/ana.410440223 · Cited by 17

Parkin and 𝛂-Synuclein: Opponent Actions in The Pathogenesis of Parkinson’S Disease

Baptista, M. J., Cookson, M., & Miller, D. W. (2004) · The Neuroscientist · doi:10.1177/1073858403260392 · Cited by 17

Mutations in the gene encoding human persyn are not associated with amyotrophic lateral sclerosis or familial Parkinson's disease

Flowers, J. M., Leigh, P. N., Davies, A. M., Ninkina, N. N., Buchman, V. L., Vaughan, J. R., Wood, N. W., & Powell, J. F. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00673-4 · Cited by 17

Synaptic vesicle-omics in mice captures signatures of aging and synucleinopathy

Gao, V., Chlebowicz, J., Gaskin, K., Briano, J. A., Komer, L. E., Pineda, A., Jhalani, S., Ahmad, S., Uwaifo, E., Black, L. S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59441-7 · Cited by 18

Role of Lipids in the Pathogenesis of Parkinson’s Disease

Kamano, S., Ozawa, D., Ikenaka, K., & Nagai, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168935 · Cited by 15

The loss of inhibitory C‐terminal conformations in disease associated P123H β‐synuclein

Janowska, M. K., & Baum, J. (2015) · Protein Science · doi:10.1002/pro.2798 · Cited by 16

The interactome of stabilized α‐synuclein oligomers and neuronal proteins

van Diggelen, F., Frank, S. A., Somavarapu, A. K., Scavenius, C., Apetri, M. M., Nielsen, J., Tepper, A. W. J. W., Enghild, J. J., & Otzen, D. E. (2019) · FEBS Journal · doi:10.1111/febs.15124 · Cited by 16

Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo

Braczynski, A. K., Sevenich, M. M., Gering, I., Kupreichyk, T., Agerschou, E. D., Kronimus, Y., Habib, P., Stoldt, M., Willbold, D., Schulz, J. B., et al. (2022) · Biomolecules · doi:10.3390/biom12030469 · Cited by 17

Modulation effect of filamentous phage on α-synuclein aggregation

Dimant, H., Sharon, N., & Solomon, B. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.048 · Cited by 16

Single injection of small-molecule amyloid accelerator results in cell death of nigral dopamine neurons in mice

Chermenina, M., Chorell, E., Pokrzywa, M., Antti, H., Almqvist, F., Strömberg, I., & Wittung-Stafshede, P. E. (2015) · npj Parkinson s Disease · doi:10.1038/npjparkd.2015.24 · Cited by 16

Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson’s disease

Pokrzywa, M., Pawełek, K., Kucia, W. E., Sarbak, S., Chorell, E., Almqvist, F., & Wittung-Stafshede, P. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184117 · Cited by 15

Are we listening to everything the PARK genes are telling us?

Benson, D. L., & Huntley, G. W. (2019) · The Journal of Comparative Neurology · doi:10.1002/cne.24642 · Cited by 17

Lewy Body Dementia

Brown, D. F. (1999) · Annals of Medicine · doi:10.3109/07853899909115977 · Cited by 16

Non-enzymatic posttranslational protein modifications in protein aggregation and neurodegenerative diseases

Baldensperger, T., Preissler, M., & Becker, C. F. W. (2024) · RSC Chemical Biology · doi:10.1039/d4cb00221k · Cited by 17

Synphilin-1-Binding Protein NUB1 is Colocalized With Nonfibrillar, Proteinase K-Resistant α-Synuclein in Presynapses in Lewy Body Disease

Tanji, K., Mori, F., Kito, K., Kakita, A., Mimura, J., Itoh, K., Takahashi, H., Kamitani, T., & Wakabayashi, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182303745 · Cited by 16

The Role ofα-Synuclein and LRRK2 in Tau Phosphorylation

Kawakami, F., & Ichikawa, T. (2015) · Parkinson s Disease · doi:10.1155/2015/734746 · Cited by 15

Amyloidosis and Longevity: A Lesson from Plants

Surguchov, A. P., Emamzadeh, F. N., & Surguchev, A. A. (2019) · Biology · doi:10.3390/biology8020043 · Cited by 14

Raman spectral imaging of 13C2H15N-labeled α-synuclein amyloid fibrils in cells

Watson, M., Flynn, J. D., & Lee, J. C. (2020) · Biophysical Chemistry · doi:10.1016/j.bpc.2020.106528 · Cited by 14

Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity

Kim, T., Newman, A. J., Imberdis, T., Brontesi, L., Tripathi, A., Ramalingam, N., Fanning, S., Selkoe, D. J., & Dettmer, U. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab188 · Cited by 17

Modelling the functional genomics of Parkinson’s disease inCaenorhabditis elegans:LRRK2and beyond

Chandler, R. J., Cogo, S., Lewis, P. A., & Kevei, É. (2021) · Bioscience Reports · doi:10.1042/bsr20203672 · Cited by 16

Orientation of α-Synuclein at Negatively Charged Lipid Vesicles: Linear Dichroism Reveals Time-Dependent Changes in Helix Binding Mode

Rocha, S., Kumar, R., Nordén, B., & Wittung-Stafshede, P. E. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c05344 · Cited by 15

α-Synuclein-positive structures induced in leupeptin-infused rats

Nakajima, T., Takauchi, S., Ohara, K., Kokai, M., Nishii, R., Maeda, S., Takanaga, A., Tanaka, T., Takeda, M., Seki, M., et al. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.099 · Cited by 15

α-Synuclein A30P decreases neurodegeneration and increases synaptic vesicle release probability in CSPα-null mice

Ruiz, R., Biea, I. A., & Tabares, L. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.032 · Cited by 15

Comparison of α-synuclein immunoreactivity and protein levels in ischemic hippocampal CA1 region between adult and aged gerbils and correlation with Cu,Zn-superoxide dismutase

Yoon, D.-K., Hwang, I. K., Yoo, K., Lee, Y.-B., Lee, J.-J., Kim, J., Kang, T., Lee, B., Sohn, H.-S., & Won, M. H. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.04.014 · Cited by 15

Spontaneous Aggregation and Altered Intracellular Distribution of Endogenous α-Synuclein During Neuronal Apoptosis

Gentile, A., Amadoro, G., Corsetti, V., Ciotti, M. T., Serafino, A., & Calissano, P. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13205 · Cited by 15

Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro α-synuclein fibril formation

Hirohata, M., Ono, K., Morinaga, A., Ikeda, T., & Yamada, M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.005 · Cited by 15

The child is father to the man: Developmental roles for proteins of importance for neurodegenerative disease

Rogers, D. A., & Schor, N. F. (2009) · Annals of Neurology · doi:10.1002/ana.21841 · Cited by 15

Small molecule-based fluorescent probes for the detection of α-Synuclein aggregation states

Haque, R., & Maity, D. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129257 · Cited by 15

The Effects of Lipids on α-Synuclein Aggregation In Vitro

Ramirez, J., Pancoe, S. X., Rhoades, E. R., & Petersson, E. J. (2023) · Biomolecules · doi:10.3390/biom13101476 · Cited by 15

α -Synuclein Trafficking in Parkinson’s Disease: Insights From Fly and Mouse Models

Cheng, J., Lu, Q., Li, S., & Ho, M. S.-C. (2018) · ASN NEURO · doi:10.1177/1759091418812587 · Cited by 14

Sumoylated α-synuclein translocates into the nucleus by karyopherin α6

Ryu, S., Baek, I., & Liew, H. (2018) · Molecular & Cellular Toxicology · doi:10.1007/s13273-019-0012-1 · Cited by 14

Alpha‐Synuclein Amyloid Oligomers Act as Multivalent Nanoparticles to Cause Hemifusion in Negatively Charged Vesicles

Stefanovic, A. N. D., Claessens, M. M. A. E., Blum, C., & Subramaniam, V. (2015) · Small · doi:10.1002/smll.201402674 · Cited by 14

Porcine γ-synuclein: molecular cloning, expression analysis, chromosomal localization and functional expression

Frandsen, P. M., Madsen, L. B., Bendixen, C., & Larsen, K. (2008) · Molecular Biology Reports · doi:10.1007/s11033-008-9270-z · Cited by 14

Neuroproteases in Peptide Neurotransmission and Neurodegenerative Diseases

HOOK, V. Y. H. (2006) · BioDrugs · doi:10.2165/00063030-200620020-00005 · Cited by 15

Alpha-synuclein levels in patients with multiple system atrophy: a meta-analysis

Yang, F., Li, W.-J., & Huang, X. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1394851 · Cited by 15

Spinocerebellar ataxia type 2 with glial cell cytoplasmic inclusions

Probst‐Cousin, S. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.011825 · Cited by 14

Comparisons of the NACP Self-Oligomerizations Induced by Aβ25-35 in the Presence of Dicyclohexylcarbodiimide and N-(Ethoxycarbonyl)-2-Ethoxy-1,2-Dihydroquinoline

Lee, J., Shin, H.-J., Chang, C., & Paik, S. R. (1998) · Neurochemical Research · doi:10.1023/a:1020711025418 · Cited by 14

Blocking the FKBP12 induced dendrimeric burst in aberrant aggregation of α-synuclein by using the ElteN378 synthetic inhibitor

Caminati, G., Martina, M. R., Menichetti, S., & Procacci, P. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1667342 · Cited by 13

miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy

Xylaki, M., Paiva, I., Al‐Azzani, M., Gerhardt, E., Jain, G., Islam, R., Vasili, E., Wassouf, Z., Schulze-Hentrich, J. M., Fischer, A., et al. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-225055 · Cited by 13

Acetylated α-Tubulin and α-Synuclein: Physiological Interplay and Contribution to α-Synuclein Oligomerization

Calogero, A. M., Basellini, M. J., Isilgan, H. B., Longhena, F., Bellucci, A., Mazzetti, S., Rolando, C., Pezzoli, G., & Cappelletti, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512287 · Cited by 13

Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice

Sano, T., Nagata, T., Ebihara, S., Yoshida‐Tanaka, K., Nakamura, A., Sasaki, A., Shimozawa, A., Mochizuki, H., Uchihara, T., Hasegawa, M., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01766-3 · Cited by 16

Strategies of positron emission tomography (PET) tracer development for imaging of tau and α-synuclein in neurodegenerative disorders

Mekala, S., Wu, Y., & Li, Y. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00576g · Cited by 13

Neural-Induced Human Adipose Tissue-Derived Stem Cells Conditioned Medium Ameliorates Rotenone-Induced Toxicity in SH-SY5Y Cells

Ramalingam, M., Jang, S., & Jeong, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052322 · Cited by 14

Truncation-Driven Lateral Association of α-Synuclein Hinders Amyloid Clearance by the Hsp70-Based Disaggregase

Franco, A., Cuéllar, J., Fernández-Higuero, J. Á., de la Arada, I., Orozco, N., Valpuesta, J., Prado, A., & Muga, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312983 · Cited by 13

The Therapeutic Potential of LRRK2 and α-Synuclein in Parkinson's Disease

Sen, S., & West, A. B. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2430 · Cited by 12

Accumulation of α-Synuclein in Cerebellar Purkinje Cells of Diabetic Rats and Its Potential Relationship with Inflammation and Oxidative Stress Markers

Solmaz, V., Özlece, H. K., Eroğlu, H. A., Aktuğ, H., Erbaş, O., & Taşkıran, D. (2017) · Neurology Research International · doi:10.1155/2017/5952149 · Cited by 13

Degradation of alpha-synuclein by dendritic cell factor 1 delays neurodegeneration and extends lifespan in Drosophila

Zhang, S., Feng, R., Li, Y., Gan, L., Zhou, F., Meng, S., Li, Q., & Wen, T. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.010 · Cited by 13

The Paradoxical Cell Biology of α-Synucle

Roy, S. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_23 · Cited by 13

α-Synuclein protein is not scavenged in neuronal loss induced by kainic acid or focal ischemia

Kitamura, Y., Ishida, Y., Takata, K., Kakimura, J., Mizutani, H., Shimohama, S., Akaike, A., & Taniguchi, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02159-x · Cited by 13

Implications of protein structure instability: From physiological to pathological secondary structure

Sukhanova, A. V., Poly, S., Shemetov, A. A., Bronstein, I. B., & Nabiev, I. R. (2012) · Biopolymers · doi:10.1002/bip.22055 · Cited by 14

The Biochemistry of Alzheimer??s Disease

Stege, G. J. J., & Bosman, G. J. C. G. M. (1999) · Drugs & Aging · doi:10.2165/00002512-199914060-00004 · Cited by 13

Target-binding behavior of IDPs via pre-structured motifs

Kim, D.-H., & Han, K. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.07.031 · Cited by 12

Exploring the effect of APOE ε4 on biomarkers of neurodegeneration in Alzheimer’s disease

Agnello, L., Gambino, C. M., Ciaccio, A. M., Piccoli, T., Blandino, V., Scazzone, C., Sasso, B. L., Ben, F. D., & Ciaccio, M. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119876 · Cited by 12

Mathematical approach to understand the kinetics of α-synuclein aggregation: Relevance to Parkinson's disease

Bharathi, P., Nagabhushan, P. N., & Rao, K. S. J. (2008) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2008.08.008 · Cited by 12

PET imaging of the influence of physiological and pathological α‐synuclein on dopaminergic and serotonergic neurotransmission in mouse models

Levigoureux, E., Bouillot, C., Baron, T., Zimmer, L., & Lancelot, S. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12978 · Cited by 12

Downregulation of α-Synuclein Protein Levels by an Intracellular Single-Chain Antibody

Chen, Y., Yu, S., Wu, K., Wang, Y.-S., Tsai, H.-M., Liao, L.-W., Chen, S., Hsieh, W., Chen, H., Hsu, S., et al. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191787 · Cited by 12

Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders

Initiative, A. D. N., Li, J., Bi, Y., Shen, X., Wang, H.-F., Xu, W., Tan, C., Dong, Q., Wang, Y., Tan, L., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00222-1 · Cited by 12

α-Synuclein and neuronal membranes: Conformational flexibilities in health and disease

Bozelli, J. C., Kamski‐Hennekam, E. R., Melacini, G., & Epand, R. M. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.105034 · Cited by 13

C-terminal truncation of α -synuclein alters DNA structure from extension to compaction

Jiang, K., Rocha, S., Kumar, R., Westerlund, F., & Wittung-Stafshede, P. E. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.06.059 · Cited by 12

Buffering capacity is determinant for restoring early α-synuclein aggregation

Saraiva, M. A., & Florêncio, M. H. (2022) · Biophysical Chemistry · doi:10.1016/j.bpc.2022.106760 · Cited by 12

The Synucleins and the Astrocyte

Myers, A. J., Brahimi, A., Jenkins, I. J., & Koob, A. O. (2023) · Biology · doi:10.3390/biology12020155 · Cited by 12

The metabolomics of alpha-synuclein (SNCA) gene deletion and mutation in mouse brain

Musgrove, R. E., Horne, J., Wilson, R., King, A. E., Edwards, L. M., & Dickson, T. C. (2013) · Metabolomics · doi:10.1007/s11306-013-0561-6 · Cited by 12

Alternative Structures of α-Synuclein

Dułak, D., Gadzała, M., Banach, M., Konieczny, L., & Roterman, I. (2020) · Molecules · doi:10.3390/molecules25030600 · Cited by 12

“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease

Ray, B., Mahalakshmi, A. M., Tuladhar, S., Bhat, A., Srinivasan, A., Pellegrino, C., Kannan, A., Bolla, S. R., Chidambaram, S. B., & Sakharkar, M. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673395 · Cited by 14

Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders

Shan, F. Y., Fung, K., Zieneldien, T., Kim, J., Cao, C., & Huang, J. H. (2021) · Life · doi:10.3390/life11111126 · Cited by 13

Caenorhabditis Elegans as a Model for Human Synucleopathies

Vartiainen, S. (2007) · Cited by 12

The Gut–Brain Axis in Parkinson's DiseasePreprint

Gao, V., Crawford, C. V., & Burré, J. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041618 · Cited by 15

Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation

Pieger, K., Schmitt, V., Gauer, C., Gießl, N., Prots, I., Winner, B., Winkler, J., Brandstätter, J. H., & Xiang, W. (2022) · Biomolecules · doi:10.3390/biom12081108 · Cited by 11

Kinetic control in amyloid polymorphism: Different agitation and solution conditions promote distinct amyloid polymorphs of alpha-synuclein

Devi, S., Garg, D. K., & Bhat, R. (2023) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2023.140917 · Cited by 11

Membrane lipids as therapeutic targets for Parkinson’s disease: a possible link between Lewy pathology and membrane lipids

Kubo, S. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1086340 · Cited by 11

An Insight into the Molecular Mechanism of Mitochondrial Toxicant-induced Neuronal Apoptosis in Parkinson’s Disease

Latchoumycandane, C., Brahadeeswaran, S., & Lateef, M. (2022) · Current Molecular Medicine · doi:10.2174/1566524022666220203163631 · Cited by 11

Lysophospholipids: A Potential Drug Candidates for Neurodegenerative Disorders

Karaki, T., Haniu, H., Matsuda, Y., & Tsukahara, T. (2022) · Biomedicines · doi:10.3390/biomedicines10123126 · Cited by 11

Stabilization of 14-3-3 protein-protein interactions with Fusicoccin-A decreases alpha-synuclein dependent cell-autonomous death in neuronal and mouse models

Vinueza‐Gavilanes, R., Bravo-González, J. J., Basurco, L., Boncristiani, C., Fernández‐Irigoyen, J., Santamaría, E., Marcilla, I., Pérez‐Mediavilla, A., Luquín, M. R., Vales, Á., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106166 · Cited by 11

LTB-Syn: a recombinant immunogen for the development of plant-made vaccines against synucleinopathies

Arévalo-Villalobos, J. I., Govea‐Alonso, D. O., Monreal‐Escalante, E., Zarazúa, S., & Rosales‐Mendoza, S. (2017) · Planta · doi:10.1007/s00425-017-2675-y · Cited by 11

Membrane–Protein–Hydration Interaction of α-Synuclein with Anionic Vesicles Probed via Angle-Resolved Second-Harmonic Scattering

Dedic, J., Rocha, S., Okur, H. İ., Wittung-Stafshede, P. E., & Roke, S. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b11096 · Cited by 12

Characterizing the inhibition of α‐synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP

Dong, C., Garen, C., Mercier, P., Petersen, N., & Woodside, M. (2019) · Protein Science · doi:10.1002/pro.3684 · Cited by 10

Protein Folding and Aggregation in in vitro Models of Parkinson's Disease

Eliezer, D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00042-7 · Cited by 11

α-Synuclein Aggregation and Parkinson’s Disease

Uversky, V. N. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_4 · Cited by 11

Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease

(2000) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(20000501)88:9

Untitled work

Mattson, M. (1999) · doi:10.1002/(sici)1097-4547(19991001)58:1

Untitled work

Goodrum (2000) · doi:10.1002/(sici)1097-4547(20000215)59:4

Untitled work

Louis (1999) · doi:10.1002/1531-8257(199905)14:3

Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease.

Masliah, E., Iwai, A., Mallory, M. E., Uéda, K., & Saitoh, T. (1996) · Europe PMC (PubMed Central) · Cited by 168

Characterization of the Precursor Protein of the Non-Aβ Component of Senile Plaques (NACP) in the Human Central Nervous System

Irizarry, M. C., Kim, T., McNamara, M. J., Tanzi, R. E., George, J. M., Clayton, D. F., & Hyman, B. T. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199608000-00004 · Cited by 205

The Non-Amyloid-β Component of Alzheimer’s Disease Plaque Amyloid: Comparative Analysis Suggests a Normal Function as a Synaptic Plasticizer

George, J. M., & Clayton, D. F. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_16 · Cited by 3

Properties of NACP/α-synuclein and its role in Alzheimer’s disease

Iwai, A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00036-3 · Cited by 78

The synaptic protein NACP is abnormally expressed during the progression of Alzheimer' s disease

Iwai, A., Masliah, E., Sundsmo, M. P., DeTeresa, R. M., Mallory, M. E., Salmon, D. P., & Saitoh, T. (1996) · Brain Research · doi:10.1016/0006-8993(96)00014-5 · Cited by 51